Bromocriptine therapy for “nonfunctioning” pituitary tumors
- 1 December 1981
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 71 (6) , 1059-1061
- https://doi.org/10.1016/0002-9343(81)90342-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- CONSERVATIVE MANAGEMENT OF PITUITARY PROLACTINOMAS; EVIDENCE FOR BROMOCRIPTINE‐INDUCED REGRESSIONBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Effects of bromocriptine on pituitary tumour size.BMJ, 1979
- REGRESSION OF PITUITARY PROLACTINOMA AFTER TREATMENT WITH BROMOCRIPTINEThe Lancet, 1979
- Regression of pituitary tumors, a possible effect of bromergocryptineThe American Journal of Medicine, 1979
- Regression of a Prolactin-Secreting Pituitary Tumor During Long-Term Treatment with BromocriptineFertility and Sterility, 1978
- Prolactin‐Secreting pituitary tumorsAnnals of Neurology, 1977
- Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cellsNature, 1975
- DNA SYNTHESIS AND THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY THE PITUITARY GLAND OF THE MALE RAT: EFFECTS OF DIETHYLSTILBOESTROL AND 2-BROMO-α-ERGOCRYPTINE METHANESULPHONATEJournal of Endocrinology, 1974
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973
- Ergot-Induced Inhibition of Pituitary Tumor Growth in RatsScience, 1972